Communiqués Bayer AG Warsaw S.E.

Actions

BAY

DE000BAY0017

Produits pharmaceutiques

Marché Fermé - Warsaw S.E. Autres places de cotation 17:55:50 03/08/2026			Varia. 5j.	Varia. 1 janv.
205,00 ^PLN	-1,77%		+1,66%	+35,59%

03/08	Agenda Zonebourse des résultats de sociétés : le 4 août 2026
03/08	Calendrier du mardi 4 août	FW

Communiqués

30/07	Bayer : submits application for next indication of Kerendia in China	PU
28/07	One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin	BU
23/07	New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters	BU
23/07	Bayer : New Economist Enterprise research highlights why integrating self-care into health systems matters	PU
17/07	Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials	BU
15/07	Bayer : signs licensing agreement with RAGT and begins broad hybrid wheat commercialization by early 2030s	PU
14/07	Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming	BU
14/07	Bayer : Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming	PU
10/07	Bayer : secures 3.0 billion euros to improve capital structure	PU
10/07	Bayer Aktiengesellschaft: Bayer secures 3.0 billion euros to improve capital structure	EQ
07/07	The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials	BU
02/07	Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart	BU
02/07	Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon	BU
02/07	Bayer : to consolidate U.S. glyphosate business into distinct entity operating as Ruveon	PU
25/06	Bayer : Monsanto wins landmark Roundup™ case at U.S. Supreme Court	PU
25/06	Immediate statement: US Supreme Court rules in favor of Monsanto in the Durnell case	PU
23/06	Vividion Therapeutics Doses First Patient in Phase Ib Combination Study of WRN Inhibitor VVD-214 in Patients with Advanced Colorectal Cancer	AQ
22/06	Bayer and Iambic Collaborate to Advance Drug Discovery with AI	BU
18/06	BAYER ACCUEILLE KACY PERRY À TITRE DE NOUVELLE CHEF NATIONALE DE CROP SCIENCE CANADA	BU
17/06	Bayer : Federal judge remands Monsanto class settlement case back to Missouri State Court	PU
17/06	Bayer Completes Acquisition of Perfuse Therapeutics	BU
16/06	Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief	BU
15/06	Bayer : Expands Open Innovation Network in China with New Hub in Shandong Province	PU
15/06	Bayer : low-dose MRI contrast agent approved in U.S.	PU
15/06	Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions	BU